The objective of this webinar series is to create a platform for international stakeholders to discuss critical topics and challenges they face when treating patients with immunotherapy, with a key goal of providing education and bringing awareness to the barriers currently impeding equitable access to IO around the globe. 

Moderator: Paolo Ascierto, MD - Instituto Nazionale Tumori IRCCS Fondazione G. Pascale

Faculty:

• Jyoti Bajpai, MD, DM - Tata Memorial Center
• Danny Khalil, MD, PhD - Memorial Sloan Kettering Cancer Center
• Taha Merghoub PhD - Weill Cornell Medicine

Webinar 6/6 content:

This webinar will examine how biomarkers are used to define “PD-L1” positive patients around the globe and in resource limited settings. It will provide a forum for physicians to discuss their experience assessing different criteria, as well as the solutions that were implemented to overcome specific challenges. Additionally, this topic will review the global availability of different platforms/clones and tumor mutational burden (TMB).